Skip to main content
. 2022 May 2;29(1):1326–1334. doi: 10.1080/10717544.2022.2069301

Figure 1.

Figure 1.

Schematic of experimental setup for in vitro evaluation of ranibizumab release from the PDS implant. To enable in vitro evaluation of drug release, PDS implants were filled with ranibizumab solution and individually suspended on custom-designed hangers, placed in 1.5-mL polypropylene tubes containing 300 µL of release buffer. Implants were transferred to new polypropylene tubes with fresh buffer at regular intervals to maintain sink conditions for ranibizumab release. Abbreviation: PDS: Port Delivery System with ranibizumab. Yohe S, Maass KF, Horvath J, Rea J, Barteselli G, Ranade SV. J Control Release. 2022;345:101–107. Licensed under CC-BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/).